Diagnostic evaluation reveals added utility of oral glucose tolerance tests in chronic idiopathic axonal polyneuropathy, indicating abnormal glucose metabolism is a major risk factor.
This study adds to emerging evidence that abnormal glucose metabolism may be a risk factor for CIAP. Even with revised (2003) ADA criteria, the 2h-OGTT provides additional diagnostic information to the health care professional in the evaluation of CIAP. Subtypes of CIAP are equally likely to have abnormal glucose metabolism.
No takes yet. Share an insight, caveat, or question.
Hoffman‐Snyder et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: